2022 加拿大西部胃肠癌共识会议的报告:免疫疗法在胃癌、食管癌和胃食管结合部癌中的当前作用

2022-04-29 Current Oncology

胃癌、食管癌和胃食管结合部癌与较差的预后相关。对于早期疾病,围手术期化疗或放化疗后手术是标准治疗。对于大多数晚期上消化道癌症患者,铂类化疗仍然是标准治疗。最近,几项随机临床试验证明了免疫治疗单独使用检

中文标题:

2022 加拿大西部胃肠癌共识会议的报告:免疫疗法在胃癌、食管癌和胃食管结合部癌中的当前作用

英文标题:

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference

发布机构:

发布日期:

2022-04-29

简要介绍:

胃癌、食管癌和胃食管结合部癌与较差的预后相关。对于早期疾病,围手术期化疗或放化疗后手术是标准治疗。对于大多数晚期上消化道癌症患者,铂类化疗仍然是标准治疗。最近,几项随机临床试验证明了免疫治疗单独使用检查点抑制剂或联合化疗对胃食管癌患者的益处,并改变了治疗前景。

相关资料下载:
[AttachmentFileName(sort=1, fileName=curroncol-29-00257.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ecb661c00261557f, title=2022 加拿大西部胃肠癌共识会议的报告:免疫疗法在胃癌、食管癌和胃食管结合部癌中的当前作用, enTitle=Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference, guiderFrom=Current Oncology, authorId=0, author=, summary=胃癌、食管癌和胃食管结合部癌与较差的预后相关。对于早期疾病,围手术期化疗或放化疗后手术是标准治疗。对于大多数晚期上消化道癌症患者,铂类化疗仍然是标准治疗。最近,几项随机临床试验证明了免疫治疗单独使用检, cover=https://img.medsci.cn/20220821/1661094711445_1608702.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Apr 29 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #212121;">胃癌、食管癌和胃食管结合部癌与较差的预后相关。</span><span style="color: #212121;">对于早期疾病,围手术期化疗或放化疗后手术是标准治疗。</span><span style="color: #212121;">对于大多数晚期上消化道癌症患者,铂类化疗仍然是标准治疗。</span><span style="color: #212121;">最近,几项随机临床试验证明了免疫治疗单独使用检查点抑制剂或联合化疗对胃食管癌患者的益处,并改变了治疗前景。</span></p>, tagList=[TagDto(tagId=438, tagName=胃癌), TagDto(tagId=751, tagName=食管癌), TagDto(tagId=8943, tagName=免疫疗法), TagDto(tagId=459754, tagName=胃食管结合部癌)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=6, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2423, appHits=57, showAppHits=0, pcHits=354, showPcHits=2362, likes=0, shares=8, comments=0, approvalStatus=1, publishedTime=Tue Aug 23 21:08:00 CST 2022, publishedTimeString=2022-04-29, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sun Aug 21 23:13:32 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 22:40:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=curroncol-29-00257.pdf)])
curroncol-29-00257.pdf
下载请点击:
评论区 (0)
#插入话题